Name
bloods_urinemicro
Label
Microalbumin, Urine
Units
ug/mL
Type
numeric
Visit number vs Microalbumin, Urine
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Baseline | 49 | 20.4 | ± 36.9 | 6.1 | 1.1 | 221.0 | - | 49 |
| 9-Month Followup | 43 | 18.8 | ± 25.5 | 9.9 | 1.0 | 118.3 | - | 43 |
| 18-Month Followup | 40 | 32.5 | ± 86.3 | 6.9 | 1.1 | 511.1 | - | 40 |
Randomized treatment arm vs Microalbumin, Urine
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 49 | 20.4 | ± 36.9 | 6.1 | 1.1 | 221.0 | - | 49 |
| Laparoscopic Gastric Banding (LGB) | 28 | 19.5 | ± 42.0 | 6.1 | 1.9 | 221.0 | - | 28 |
| Continuous Positive Airway Pressure (CPAP) | 21 | 21.6 | ± 29.7 | 7.2 | 1.1 | 123.2 | - | 21 |
Randomized treatment arm vs Microalbumin, Urine
9-Month Followup
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 43 | 18.8 | ± 25.5 | 9.9 | 1.0 | 118.3 | - | 43 |
| Laparoscopic Gastric Banding (LGB) | 25 | 15.4 | ± 20.1 | 9.9 | 1.0 | 97.7 | - | 25 |
| Continuous Positive Airway Pressure (CPAP) | 18 | 23.4 | ± 31.5 | 11.1 | 1.3 | 118.3 | - | 18 |
Randomized treatment arm vs Microalbumin, Urine
18-Month Followup
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 40 | 32.5 | ± 86.3 | 6.9 | 1.1 | 511.1 | - | 40 |
| Laparoscopic Gastric Banding (LGB) | 24 | 29.7 | ± 103.2 | 5.6 | 1.1 | 511.1 | - | 24 |
| Continuous Positive Airway Pressure (CPAP) | 16 | 36.6 | ± 54.9 | 19.4 | 2.6 | 227.6 | - | 16 |
Age of the participant vs Microalbumin, Urine
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 49 | 20.4 | ± 36.9 | 6.1 | 1.1 | 221.0 | - | 49 |
| 27.0 to 45.0 years | 13 | 20.1 | ± 32.8 | 7.2 | 3.6 | 123.2 | - | 13 |
| 46.0 to 50.0 years | 12 | 14.8 | ± 20.7 | 5.7 | 1.1 | 68.9 | - | 12 |
| 51.0 to 56.0 years | 12 | 23.2 | ± 19.5 | 22.3 | 2.6 | 63.3 | - | 12 |
| 57.0 to 65.0 years | 12 | 23.7 | ± 62.4 | 3.8 | 1.9 | 221.0 | - | 12 |
Age of the participant vs Microalbumin, Urine
9-Month Followup
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 43 | 18.8 | ± 25.5 | 9.9 | 1.0 | 118.3 | - | 43 |
| 28.0 to 47.0 years | 11 | 31.2 | ± 37.6 | 15.5 | 1.3 | 118.3 | - | 11 |
| 47.0 to 52.0 years | 11 | 9.7 | ± 5.9 | 9.3 | 2.9 | 22.0 | - | 11 |
| 52.0 to 58.0 years | 11 | 20.6 | ± 28.6 | 12.2 | 1.0 | 97.7 | - | 11 |
| 58.0 to 65.0 years | 10 | 12.9 | ± 13.6 | 8.5 | 1.1 | 37.9 | - | 10 |
Age of the participant vs Microalbumin, Urine
18-Month Followup
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 40 | 32.5 | ± 86.3 | 6.9 | 1.1 | 511.1 | - | 40 |
| 29.0 to 46.0 years | 10 | 39.3 | ± 68.6 | 10.1 | 3.5 | 227.6 | - | 10 |
| 47.0 to 52.0 years | 10 | 16.8 | ± 21.8 | 9.7 | 1.4 | 71.9 | - | 10 |
| 53.0 to 58.0 years | 10 | 14.2 | ± 16.1 | 7.6 | 3.0 | 53.7 | - | 10 |
| 58.0 to 65.0 years | 10 | 59.6 | ± 159.1 | 3.4 | 1.1 | 511.1 | - | 10 |
Gender of the participant vs Microalbumin, Urine
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 49 | 20.4 | ± 36.9 | 6.1 | 1.1 | 221.0 | - | 49 |
| Male | 28 | 26.6 | ± 46.6 | 8.1 | 2.5 | 221.0 | - | 28 |
| Female | 21 | 12.1 | ± 14.4 | 5.3 | 1.1 | 53.3 | - | 21 |
Gender of the participant vs Microalbumin, Urine
9-Month Followup
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 43 | 18.8 | ± 25.5 | 9.9 | 1.0 | 118.3 | - | 43 |
| Male | 25 | 25.8 | ± 30.9 | 13.2 | 1.1 | 118.3 | - | 25 |
| Female | 18 | 9.0 | ± 9.0 | 6.5 | 1.0 | 33.9 | - | 18 |
Gender of the participant vs Microalbumin, Urine
18-Month Followup
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 40 | 32.5 | ± 86.3 | 6.9 | 1.1 | 511.1 | - | 40 |
| Male | 25 | 42.3 | ± 107.5 | 8.1 | 1.1 | 511.1 | - | 25 |
| Female | 15 | 16.1 | ± 21.7 | 4.8 | 1.7 | 71.9 | - | 15 |
Race of the participant vs Microalbumin, Urine
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 46 | 21.1 | ± 37.9 | 6.7 | 1.1 | 221.0 | - | 46 |
| white | 35 | 19.7 | ± 38.2 | 6.1 | 1.9 | 221.0 | - | 35 |
| american indian or alaska native | - | - | - | - | - | - | - | - |
| black or african american | 9 | 16.6 | ± 23.2 | 7.8 | 1.1 | 68.9 | - | 9 |
| asian | 2 | 65.2 | ± 82.0 | 65.2 | 7.2 | 123.2 | - | 2 |
| native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
| other | - | - | - | - | - | - | - | - |
| multiple | - | - | - | - | - | - | - | - |
Race of the participant vs Microalbumin, Urine
9-Month Followup
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 40 | 19.5 | ± 26.2 | 10.4 | 1.0 | 118.3 | - | 40 |
| white | 31 | 21.9 | ± 28.9 | 12.2 | 1.0 | 118.3 | - | 31 |
| american indian or alaska native | - | - | - | - | - | - | - | - |
| black or african american | 8 | 12.7 | ± 11.1 | 9.7 | 1.2 | 37.9 | - | 8 |
| asian | 1 | 1.3 | - | 1.3 | 1.3 | 1.3 | - | 1 |
| native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
| other | - | - | - | - | - | - | - | - |
| multiple | - | - | - | - | - | - | - | - |
Race of the participant vs Microalbumin, Urine
18-Month Followup
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 37 | 33.8 | ± 89.6 | 7.0 | 1.1 | 511.1 | - | 37 |
| white | 29 | 39.7 | ± 100.6 | 6.5 | 1.1 | 511.1 | - | 29 |
| american indian or alaska native | - | - | - | - | - | - | - | - |
| black or african american | 7 | 11.9 | ± 8.5 | 8.1 | 2.2 | 25.6 | - | 7 |
| asian | 1 | 13.4 | - | 13.4 | 13.4 | 13.4 | - | 1 |
| native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
| other | - | - | - | - | - | - | - | - |
| multiple | - | - | - | - | - | - | - | - |